Using IHC to Predict Local Recurrence/Progression of DCIS: A Search for a More Cost-effective Solution

Breast J. 2016 Mar-Apr;22(2):247-8. doi: 10.1111/tbj.12561. Epub 2015 Dec 23.

Authors

Mark R Kilgore¹, Oliver H Chang¹, Paul E Swanson¹, Rodney A Schmidt¹, Rochelle L Garcia¹, Mara H Rendi¹

Affiliation

¹ Department of Pathology, University of Washington, Seattle, Washington.

PMID: 26696338
DOI: 10.1111/tbj.12561

No abstract available

Publication types

Letter

MeSH terms

Biomarkers, Tumor / metabolism*
Breast Neoplasms / metabolism
Breast Neoplasms / pathology*
Breast Neoplasms / therapy
Carcinoma, Intraductal, Noninfiltrating / metabolism
Carcinoma, Intraductal, Noninfiltrating / pathology*
Carcinoma, Intraductal, Noninfiltrating / therapy
Case-Control Studies
Cost-Benefit Analysis
Female
Histones / metabolism
Humans
Immunohistochemistry / economics
Immunohistochemistry / methods*
Ki-67 Antigen / metabolism
Mastectomy
Mastectomy, Segmental
Neoplasm Recurrence, Local

Substances

Biomarkers, Tumor
Histones
Ki-67 Antigen